Lymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York

Similar documents
Lymphoma and Pseudolymphoma

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

FOLLICULARITY in LYMPHOMA

Immunopathology of Lymphoma

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.

Cutaneous Lymphoid Proliferations: A Comprehensive Textbook of Lymphocytic Infiltrates of the Skin

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Primer of Immunohistochemistry (Leukocytic)

ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas

Important Decisions in Dermatopathology: The Clinico- Pathologic Correlation. Dermatopathology Specialists Needed. Changing Trends

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia

Small B-cell (Histologically Low Grade) Lymphoma

Contents. vii. Preface... Acknowledgments... v xiii

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Plasma cell myeloma (multiple myeloma)

Use of PD-1, CD1a, and S-100 in Differentiating Pseudolymphomatous Folliculitis and Indolent Primary Cutaneous B-Cell Lymphomas

Case 3. Ann T. Moriarty,MD

Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders

Many of the hematolymphoid disorders are derived

Hepatic Lymphoma Diagnosis An Algorithmic Approach

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

Diagnosis of lymphoid neoplasms has been

Michi Shinohara MD Associate Professor University of Washington/Seattle Cancer Care Alliance Dermatology, Dermatopathology

Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Cover Page. The handle holds various files of this Leiden University dissertation.

Methods used to diagnose lymphomas

Unusual cutaneous presentation of a T-cell lymphoproliferation

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

New Haven, Connecticut

3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships

Disclosures. Advisory Board. Consultant. Investigator. MiRagen, Actelion, Celgene, Therakos. Mindera

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory

Bone Marrow. Procedures Blood Film Aspirate, Cell Block Trephine Biopsy, Touch Imprint

Large cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s

GENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute

, , 2011 HODGKIN LYMPHOMA

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018

A Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D.

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Review Article. Cutaneous lymphoproliferative disorders. NJ Trendell-Smith

Session Summary session 6. Reactive Lymphoproliferations of the skin. Session 6 - case 211

Low-grade B-cell lymphoma

Pathology of Hematopoietic and Lymphoid tissue

Hematopathology Specialty Conference Case #1

Pathology of the indolent B-cell lymphomas Elias Campo

Thomas Hodgkin and Hodgkin lymphoma

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Granulomatous Slack Skin with an unusually aggressive course due to the subsequent development of a CD30-positive Large Cell Lymphoma

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO

Primary Cutaneous Follicle Center Lymphoma Associated With an Extracutaneous Dissemination

Follicular Lymphoma: the WHO

Non-Hodgkin Lymphoma in Clinically Difficult Situations

Non-Hodgkin s Lymphomas Version

Prepared by: Dr.Mansour Al-Yazji

T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma

Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307

Approach to Core Biopsy Specimens

LYMPHOMAS an overview of some subtypes of NHLs

Thyroiditis in the differential diagnosis of lymphoma

Corrigenda. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition): corrections made in second print run

1/14/2018. Objectives

Primary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report

Low grade High grade , immune suppression chronic persistent inflammation viruses B-symptoms

SEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology

Composite mantle cell and follicular lymphoma. A case report

Conjunctival CD5+ MALT lymphoma and review of literatures

Lymph node cytopathology : A practical approach to lymphoproliferative disorders

CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting

ISIMM Tata Conference on Immunohistochemistry. Kolkata, India, January Immunohistochemistry. A cost effective approach to lymphoma diagnosis

21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Classification of Cutaneous T cell Lymphomas (CTCLs) Hernani Cualing, MD

Lymphoma Read with the experts

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3

Session 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi

Pathology of Hematopoietic and Lymphoid tissue

Test Utilization: Chronic Lymphocytic Leukemia

The spectrum of flow cytometry of the bone marrow

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

Classifications of lymphomas

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham

Peripheral blood Pleural effusion in a cat

الفتوي الاصفر الحبيبوم = Xanthogranuloma_Juvenile JUVENILE XANTHOGRANULOMA 1 / 9

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

Key words: diagnosis, immunoglobulin G4, immunoglobulin G4-related diseases, immunohistochemistry, pseudolymphoma. CASE HISTORY

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

Transcription:

Lymphocytoma Cutis Cynthia M. Magro MD Professor of Pathology Director of Dermatopathology Weill Medical College of Cornell University New York, New York

Lymphocytoma Cutis Falls under other designations including cutaneous lymphoid hyperplasia, pseudolymphoma, lymphadenosis benigna cutis Basic reaction pattern: diffuse and or nodular well differentiated lymphocytic infiltrate Raises diagnostic consideration regarding certain types of lymphoma: MZL, FCCL, primary cutaneous pleomorphic T cell lymphoma, and Hodgkin lymphoma Unusual PL variants including Kimura s disease, angiolymphoid hyperplasia, unilesional Castleman s disease, cutaneous plasmacytosis, pseudolymphomatous folliculitis

Lymphocytoma Cutis Pathogenetic Basis: Excessive reactive lymphoid proliferation provoked by antigen(arthropod, Borrelia,herpes, contactant, vaccination ) Iatrogenic/endogenous immune dysregulation Iatrogenic: drugs which suppress T regulatory cell function(prozac, elavil, antihistamines, phytoestrogen) sometimes for many years with no temporal association (Magro and Crowson, Human pathol 1996) Endogenous: RA, SS, lymphotropic viral infection, CLL, mantle cell lymphoma Caveat: likely the first step toward lymphoma, hence lesions exhibiting borderline/atypical features are not uncommon (i.e the concept of lymphomagenesis)

Case 1 The patient was a 48 year old female who presented with a nodule on the nose of 3 weeks duration. The patient was on antihistamines for seasonal allergies for several years(c Magro, AN Crowson. Drugs with antihistaminic properties as a cause of atypical lymphoid hyperplasia JAAD 1995).

Nodular lymphocytic infiltrate Zonation pattern:germinal centers with a peripheral cuff of lsmall ymphocytes Heaviest in superficial and mid dermis

Germinal center CD3 CD20

Case 2 A 54 year old male developed a solitary nodule on the face over a period of a few weeks Long standing antidepressant therapy Otherwise asymptomatic

Reactive histiocytic component Reactive germinal center

CD3 CD20

CD4 CD7 CD3 ( Red) Programmed Death marker CD3( R) PD1( B) in GC

CD21 Bcl6 B c Summary of phenotypic profile: Dominance of T cells over B cells T cells are without any phenotypic abnormalities There are scattered follicular T cells in reactive germinal centers as revealed By co-localization of CD3 and PD1 The germinal centers appear normal light microscopically and phenotypically Including the preserved dendritic network l 6

Diagnosis Well differentiated diffuse T cell dominant lymphocytic infiltrate B cell component: minor primarily in the context of reactive germinal center and mantle zones No phenotypic aberrations amidst the B cell component T cell component: CD4 dominant, without phenotypic abnormalities Polyclonal result Diagnosis: Lymphocytoma cutis

CD4 + small/medium-sized pleomorphic T-cell lymphoma Sudden onset of nodules Dense diffuse/nodular infiltrate of small/ medium pleomorphic T-cells; large atypical cells <30%; adnexal destruction is common. CD7 loss is most common Monoclonality in 60% of cases A subset of the cells have been proposed to be follicular helper T cells; large and atypical, NOT> 30% exhibiting BCL6/PD1/CXCL13/CD57 forming rosettes around CD30 positive B cells. The B cell component is invariably present, up to 50% of the infiltrate

PD1 Programmed cell death 1 is an inhibitory member of the CD28 family located on chromosome 2q37 that is expressed on follicular helper T cells but also in activated T and B cells, macrophages PD1 and its ligands PD-L1/ PD-L2 deliver inhibitory signals that regulate the balance between T cell activation and tolerance High levels of infiltrating PD-1 positive lymphocytes may be associated with decreased survival in lymphoma and other malignancies

Follicular HelperT cells promote germinal center B cell survival and differentiation, allow immunoglobulin class switching and somatic hypermutation Hence the neoplastic T cells in primary cutaneous pleomorphic T cell lymphoma promote B cell hyperplasia. Follicular helper T cells are implicated in angioimmunoblastic lymphoma, peripheral T cell lymphoma with a follicular pattern ((5;9) q33;q32) translocation), and primary cutaneous pleomorphic T cell lymphoma

Differential diagnosis of lymphocytoma cutis:low grade B cell Lymphoma CD20 An example of primary Cutaneous Follicle Center Cell Lymphoma Cell CD 3 A dominance of B cells over T cells Is always indicative of B cell lymphoma 1.Reversal of T/B ratio 2.Effacing infiltrate 3.Extension into fat 4. Bottom heavy

Infiltrate extending into fat and skeletal muscle Reversal of T/B ratio Lineage infidelity as revealed by CD43staining CD3 CD43 CD20

Reactive states: Kappa mrna exceeds lambda mrna range 3:1 to 5:1 Light chain restriction: K:L >5:1;equalization of K/L or any excess of L Magro C et al. Kappa and Lambda mrna expression in the assessment Of B cell clonality in cutaneous B cell infiltrates JCP 2003. Case illustrated: MZL with lambda light chain restriction Lambda Kappa

CD23 Lymphocytoma Cutis Identifying the Reactive Germinal Center Organized dendritic cell network (CD23,CD21) High Proliferation index BCL2 BCL6/CD10+ Cuff of reactive T/ mantle zone B cells Lack of infiltration of GC by small non GC B cells

Features of Germinal Centers in the setting of B cell lymphoma CD23 BCL-2 1.MZL colonizing a GC resulting in dendritic cell lysis 2. True neoplastic GCs Low Proliferation index BCL2+:centroblasts and centrocytes Zones of dendritic cell lysis CD10/CD79 deletion CD23

Case 3 73 year old man with a scalp lesion clinically compatible with a nodular basal cell carcinoma.

CD3 CD20 CD7

Diagnosis Benign features Well differentiated mixed T and B cell infiltrate with a dominance of T cells over B cells. T cells appear reactive B cell component includes reactive germinal centers and overall appears well differentiated Polyclonal molecular result. A significant component of the lesion=lymphocytoma cutis

bcl2 BCL-6 CD10 cd10 CD23 CD21

Diagnosis Atypical features: Collections of atypical centroblastic cells highlighted by Bcl6 BCL6 foci are irregular with infiltrative margins; CD10, CD23,CD21 negative Diagnosis: probable evolving low grade B cell lymphoproliferative disorder arising in a background of LC ; transition into early follicle center cell lymphoma cannot be excluded.

Case # 4 57 year old female with a history of a left neck mass involving the skin and subcutaneous tissue. After a 7 day course of antibiotics an After a 7 day course of antibiotics an excisional biopsy was performed.

CD3 CD20 Pax5 colocalized with CD30; the CD30 cells are negative CD21

Diagnosis Benign features Well differentiated T and B cell lymphocytic infiltrate Dominance of T cells over B cells Discrete zonation pattern Polyclonal infiltrate No abnormalities amidst T cells No diagnostic phenotypic abnormalities amidst B cells

Atypical features Diagnosis Massive effacing quality of the infiltrate Extensive infiltration of reactive germinal centers by small CD20+ CD23- B cells (post germinal center B cells) defining the concept of progressive transformation of germinal centers Diagnosis: Lymphocytoma cutis; given the presence of progressive transformation of the germinal centers MZL cannot be excluded.

Progressive Transformation of Germinal Centers Definition: larger than normal germinal centers which are infiltrated by mantle zone/post germinal center B lymphocytes Characteristically affects lymph nodes Described in certain nodal lymphomas Pediatric marginal zone nodal lymphoma Nodular lymphocyte predominant HL Floral follicular lymphoma Peripheral T cell lymphoma with follicular growth pattern Rare reports in skin in the context of pseudolymphoma

Case #5 66 year old healthy woman with a 3 month history of solitary firm nodule (6 x9 millimeters) behind the left ear. She is not on any medication. Differential diagnosis: Low grade B cell lymphoproliferative lesion versus lymphocytoma cutis.

CD3 CD20

Lambda Kappa CD20 CD79

Diagnosis Well differentiated mixed T and B cell lymphocytic infiltrate Polyclonal No phenotypic abnormalities amidst T cells No obvious cytologic atypia Focal phenotypic abnormalities: reduction in CD79 A and dominance of Lambda over Kappa. Diagnosis: suspicious for an evolving low grade B cell lymphoproliferative disorder (I.e. marginal zone lymphoma) arising in a background of lymphocytoma cutis.

Comparison of CD20/CD79A Examining the expression of CD79A amidst B cells compared to CD20 is useful in the assessment of possible B cell lymphoproliferative disease CD79A is a B lymphocyte antigen receptor that is used for identifying B-cell lineage CD79A appears early in B-cell maturation at the pre-b-cell stage, and persists until the late plasma cell stage and is present before CD20 is expressed and persists after CD20 is lost(i.e. plasma cell)

Case # 6 1 year old male developed a plaque on the cheek in October 2005. Plaque was temporally associated with an upper respiratory tract infection. Patient s history was remarkable for multiple episodes of otitis media and hypersensitivity to nuts.

CD7 CD3

Diagnosis Diffuse well differentiated T cell dominant infiltrate CD3+CD4+ dominant infiltrate with a slight reduction in CD7;no reduction in CD62L,CD5 Clonality by PCR Based on the age of the patient, well differentiated appearance of the infiltrate and lack of significant phenotypic abnormalities amidst the T cells, a diagnosis of clonally restricted T cell rich lymphocytoma cutis was favored.

Clonality in the setting of Pseudolymphoma T cell clonality is not uncommon and in isolation of other features supportive of lymphoma (i.e. cytology, architecture and phenotypic profile) should not be the sine que non of malignancy In contrast, B cell clonality is uncommon in reactive lymphocytic infiltrates and suggests an evolving B cell lymphoproliferative disorder T and or B cell pseudoclonality may be seen if there are sparse T and B cell infiltrates, respectively

Concluding Remarks Cases 1,2: where the biopsy is not a diagnostic dilemma ( T cell dominant infiltrate with neither phenotypic and or cytologic atypia amidst T and B cells ) Indeterminate cases 3-6: select atypical features in a background of reactive lymphoid hyperplasia; some of these cases may represent stepwise progression to overt lymphoma (analogous to the borderline concept of melanoma-genesis)

Concluding Remarks Reactive: mixed T and B cell infiltrate without cytologic atypia,clonality and phenotypic abnormalities Low grade B or T cell Lymphoma: dominant T and or B cell infiltrate, clonality (not in every case), recognizable cytologic atypia and phenotypic abnormalities involving more than just focal areas in a biopsy Indeterminate: certain light microscopic, phenotypic and or molecular features that one associates with lymphoma although the dominant picture is more typical of lymphocytoma cutis

Question 1 Progressive transformation of the germinal center can be seen in which conditions: 1. Lymphocytoma cutis 2. Marginal Zone lymphoma 3. Nodular Lymphocyte predominant Hodgkin lymphoma 4. All of the above

Answer All of the Above Progressive transformation of the germinal center refers to expansion of a benign germinal center by small mature mantle zone B lymphocytes. It does not always equate with low grade B cell lymphoma ; in the skin it has been described in lesions of lymphocytoma cutis Reference:Nguyen PL et al. Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study. Am J Surg Pathol. 1999 Jan;23(1):27-33.

Question 2 Features of Primary cutaneous small/medium sized pleomorphic T cell lymphoma include all of the following except 1. Low grade lymphoma 2.A possible neoplasm of follicular helper T cells. 3. Possible diminution in select pan T cell markers, primarily CD7 4. Slow onset of plaques and nodules analogous to mycosis fungoides 5. The distinction from clonally restricted lymphocytoma cutis is difficult

Answer to question 2 Number 4 In primary cutaneous pleomorphic T cell lymphoma there is a sudden onset of nodules and plaques rather than the indolent course that typifies mycosis fungoides. Beltraminelli H, Leinweber B, Kerl H, Cerroni L. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. 2009 Jun;31(4):317-22. PubMed PMID:

Question 3 The following are true for lymphocytoma cutis except 1.Dominance of T cells over B cells 2. T cell clonality is more commonly observed than B cell clonality 3. A drug based etiology is frequently implicated 4. A dominance of kappa over lambda may imply an evolving low grade B cell lymphoproliferative lesion

Answer to Question 3 Number 4 Kappa positive plasma cells always dominate over lambda and therefore this particular scenario would not be diagnostic of a low grade B cell lymphoproliferative disorder. If the kappa to lambda ratio was in excess of 5:1 then there would be a concern regarding a low grade B cell lymphoproliferative lesion. Magro C et al Automated kappa and lambda light chain mrna expression for the assessment of B-cell clonality in cutaneous B- cell infiltrates: its utility and diagnostic application. J Cutan Pathol. 2003 Sep;30(8):504-11.